Primary hyperparathyroidism with PTH values within the reference range: clinical case of a patient with recurrent nephrolithiasis

Hyperparathyroidism is an endocrine disease characterized by excessive secretion of parathyroid hormone (PTH) by the parathyroid glands. Primary hyperparathyroidism (PHPT) can be diagnosed biochemically with the combination of hypercalcemia and upper-normal or elevated levels of PTH. There are few descriptions of PHPT with normal intact PTH secretion in the literature. The incidence of PHPT among patients with recurrent urolithiasis is 2–8%. We present a clinical case of diagnosing PHPT in a 64-year-old female patient with rare variant of the disease. Before establishing the diagnosis, the main patient complaints were long-term recurrent nephrolithiasis and nephrocalcinosis. Surgical treatment made it possible to achieve rapid normalization of biochemical parameters of calcium-phosphorus metabolism, increase bone mineral density in the lumbar spine, improve the general condition of the patient. This clinical case demonstrates errors and late diagnosis of PHPT associated with poor knowledge of the manifestations of hyperparathyroidism and its masks. The authors recommend to determine the concentrations of total calcium, albumin, serum levels of PTH in patients with clinical picture of PHPT, in order to exclude the disease.

1. Мокрышева Н.Г., Рожинская Л.Я., Кузнецов Н.С., и др. Клинические рекомендации Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения // Проблемы эндокринологии. – 2016. – Т. 62. – №6. – С. 40-77. [Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2017;62(6):40-77. (In Russ).] DOI:10.14341/probl201662640-77

2. Bilezikian JP. Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018;103(11):3993-4004. DOI:10.1210/jc.2018-01225

3. Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391(10116):168-178. DOI:10.1016/S0140-6736(17)31430-7

4. Bilezikian JP, Cusano NE, Khan AA, et al. Primary hyperparathyroidism. Nat Rev Dis Prim. 2016;2(1):16033. DOI:10.1038/nrdp.2016.33

5. Thakker R V. Genetics of parathyroid tumours. J Intern Med. 2016;280(6):574-583. DOI:10.1111/joim.12523

6. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17 Suppl 2(6):N18-23. PMID: 12412773

7. Mischis-Troussard C. Primary hyperparathyroidism with normal serum intact parathyroid hormone levels. QJM. 2000;93(6):365-367. DOI:10.1093/qjmed/93.6.365

8. Pang C, Fan Y, Zhang H, et al. Case report: incidental parathyroid adenoma in a Chinese diabetic patient with hypercalcemia and normal parathyroid hormone levels. Medicine (Baltimore). 2018;97(28):e11333. DOI:10.1097/MD.0000000000011333

9. Benaderet AD, Burton AM, Clifton-Bligh R, Ashraf AP. Primary Hyperparathyroidism with Low Intact PTH Levels in a 14-Year-Old Girl. J Clin Endocrinol Metab. 2011;96(8):2325-2329. DOI:10.1210/jc.2011-0247

10. Goltzman D. Physiology of Parathyroid Hormone. Endocrinol Metab Clin North Am. 2018;47(4):743-758. DOI:10.1016/j.ecl.2018.07.003

11. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med. 1999;106(2):238-253. DOI:10.1016/S0002-9343(98)00418-5

12. Moallem E, Kilav R, Silver J, Naveh-Many T. RNA-Protein Binding and Post-transcriptional Regulation of Parathyroid Hormone Gene Expression by Calcium and Phosphate. J Biol Chem. 1998;273(9):5253-5259. DOI:10.1074/jbc.273.9.5253